Jerry Bui

Managing Director, Technology

Dallas, TX||+1 940 205 0898

Jerry Bui is a Managing Director in FTI Consulting’s Technology segment and is based in Dallas. Mr. Bui has more than 20 years of experience assisting clients with technology-related aspects of investigations. Mr. Bui’s practice often focuses on leading complex electronic discovery efforts and conducting in-depth forensic examinations. He has testified more than 15 times in support of civil matters.

Mr. Bui’s clients include major companies within the areas of pharmaceutical life sciences, medical device, big tech and other industries. He regularly assists clients through all phases of investigations, helping them to understand their options when responding to government subpoenas and requests from opposing parties. Mr. Bui has testified in support of civil spoliation motions as well as on topics such as proper e-discovery procedures, the adequacy of efforts undertaken by opposing parties and topics related to the theft of trade secret information.

Mr. Bui is often personally requested to conduct in-depth forensic examinations of computers used by key persons of interest and to provide expert courtroom testimony to support his findings. In addition to his client-based responsibilities, Mr. Bui is also a diversity ambassador for the firm and promotes professional development in the Asian-American Pacific Islander (AAPI) community. Prior to joining FTI Technology, Mr. Bui was the Executive Director of Forensics at Lighthouse, where he acted as the global leader of digital forensic services and evidence collection for investigation and litigation matters and was responsible for the development of proactive risk management consulting services.

Previously, at PricewaterhouseCoopers, Mr. Bui was the Advisory Director of Forensic Technology Services and Investigative Analytics, where he focused on global supply chain fraud and compliance solutions in pharmaceutical life sciences and food trust. Mr. Bui was responsible for advising clients on regulatory affairs and enforcement trends involving the Food and Drug Administration and Department of Justice as it related to false claims, anti-bribery and anti-corruption and food safety. He has also held leadership positions at Ernst and Young, KPMG and Navigant Consulting. 

  Back to experts